Horizon Therapeutics Public Ltd Co Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Horizon Therapeutics Public Ltd Co quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Common Stock, Shares, Issued for the quarter ending June 30, 2023 was 229M shares, a 0.6% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 229M -1.39M -0.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 229M -913K -0.4% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 228M -135K -0.06% Dec 31, 2022 10-Q 2023-08-08
Q3 2022 229M +2.05M +0.9% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 231M +4.62M +2.04% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 230M +4.85M +2.15% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 228M +6.04M +2.72% Dec 31, 2021 10-K 2023-03-01
Q3 2021 227M +6.03M +2.73% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 226M +26.1M +13.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 225M +34.1M +17.8% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 222M +33.3M +17.7% Dec 31, 2020 10-K 2022-03-01
Q3 2020 221M +33.8M +18.1% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 200M +13.5M +7.25% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 191M +5.83M +3.15% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 188M +19.2M +11.3% Dec 31, 2019 10-K 2021-02-24
Q3 2019 187M +19.3M +11.5% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 186M +19.5M +11.7% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 185M +19.8M +12% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 169M +4.46M +2.71% Dec 31, 2018 10-K 2020-02-26
Q3 2018 168M +3.67M +2.23% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 167M +3.28M +2% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 165M +2.35M +1.44% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 165M +2.78M +1.72% Dec 31, 2017 10-K 2019-02-27
Q3 2017 164M +2.62M +1.62% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 164M +2.57M +1.6% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 163M +2.37M +1.48% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 162M +1.94M +1.21% Dec 31, 2016 10-K 2018-02-28
Q3 2016 162M +1.97M +1.23% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 161M +2.39M +1.51% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 161M +27M +20.2% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 160M +35.6M +28.6% Dec 31, 2015 10-K 2017-02-27
Q3 2015 160M +53.5M +50.4% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 159M +84.4M +114% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 134M +62.3M +87.2% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 124M +58.3M +88.2% Dec 31, 2014 10-K 2016-02-29
Q3 2014 106M +40.3M +61.2% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 74.3M +11M +17.3% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 71.4M +9.47M +15.3% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 66.1M +4.38M +7.09% Dec 31, 2013 10-K/A 2015-03-02
Q3 2013 65.9M +4.82M +7.9% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 63.3M +29.6M +87.6% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 61.9M +28.2M +83.8% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 61.7M +42.1M +214% Dec 31, 2012 10-K 2014-03-13
Q3 2012 61M +41.5M +213% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 33.7M +32.3M +2155% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 33.7M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 19.6M +18.1M +1217% Dec 31, 2011 10-K 2013-03-18
Q3 2011 19.5M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 1.5M Jun 30, 2011 10-Q 2011-09-02
Q4 2010 1.49M Dec 31, 2010 10-K 2012-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.